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Abstract
A greater understanding of the causes of human disease can come from identifying characteristics that are specific to
disease genes. However, a full understanding of the contribution of essential genes to human disease is lacking, due to the
premise that these genes tend to cause developmental abnormalities rather than adult disease. We tested the hypothesis
that human orthologs of mouse essential genes are associated with a variety of human diseases, rather than only those
related to miscarriage and birth defects. We segregated human disease genes according to whether the knockout
phenotype of their mouse ortholog was lethal or viable, defining those with orthologs producing lethal knockouts as
essential disease genes. We show that the human orthologs of mouse essential genes are associated with a wide spectrum
of diseases affecting diverse physiological systems. Notably, human disease genes with essential mouse orthologs are over-
represented among disease genes associated with cancer, suggesting links between adult cellular abnormalities and
developmental functions. The proteins encoded by essential genes are highly connected in protein-protein interaction
networks, which we find correlates with an over-representation of nuclear proteins amongst essential disease genes.
Disease genes associated with essential orthologs also are more likely than those with non-essential orthologs to contribute
to disease through an autosomal dominant inheritance pattern, suggesting that these diseases may actually result from
semi-dominant mutant alleles. Overall, we have described attributes found in disease genes according to the essentiality
status of their mouse orthologs. These findings demonstrate that disease genes do occupy highly connected positions in
protein-protein interaction networks, and that due to the complexity of disease-associated alleles, essential genes cannot be
ignored as candidates for causing diverse human diseases.
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Introduction
Much effort has been invested in identifying the set of genes
that when mutated have a causal relationship with human
disease. While many characteristics of genes associated with
disease have been examined, prior studies have presumed that
these disease genes form a homogeneous group sharing particular
characteristics, distinct from non-disease genes [1,2,3,4]. Further
studies that classified disease genes based on their requirement
during development, or essentiality, led to the conclusion that the
majority of disease genes are non-essential [5,6,7,8]. This
conclusion is drawn from the analysis of human disease genes
based on the phenotypes of their mouse orthologs. Disease genes
whose mouse orthologs produce lethal phenotypes when deleted
were considered essential, and all other genes considered non-
essential. This classification, however, over-estimates the size of
the non-essential gene group, due to the inclusion of genes with
no reported knockout data. As currently only approximately 9%
of mouse genes have been knocked out (Dataset S1), it is very
likely that disease genes with no known mouse knockout
phenotype would include both lethal and viable genes. Therefore,
to include genes with no knockout data in the viable gene group
confounds the analysis, and could lead to erroneous conclusions
about the relative importance of lethal and viable genes in human
disease.
It has also been proposed that mutations in the human
orthologs of essential mouse genes will cause lethality in human
pregnancies, accounting for spontaneous miscarriages [5,9]. The
authors of one study therefore conclude that essential genes are not
human disease genes [9], as mutations prevent viability. However,
this assumption fails to consider the impact of alleles on gene
function. Genes have been defined as essential due to the
phenotype of mouse knockouts, which result from a deletion of
the protein-coding region of the gene from the genome. These
mouse mutants therefore are null alleles, and represent the
phenotype caused by complete absence of functional protein.
However, point mutations in these same genes do not necessarily
fully remove protein function. Gene alleles with reduced function,
called hypomorphic alleles, therefore can generate different
phenotypes from those of null alleles. Although null or severe
loss-of-function mutations in essential genes may indeed contribute
to spontaneous miscarriages, hypomorphic mutations in the same
genes can contribute to less severe abnormalities that are
recognized as human disease. Therefore, the human orthologs of
genes required for embryonic development in the mouse can cause
disease in mutated forms through a variety of mechanisms. For
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congenital birth defects in a manner that resembles their mouse
knockout phenotypes [10,11,12,13]. Other orthologs of mouse
essential genes show haploinsufficiency in the human, such that
they cause an abnormal phenotype in the heterozygous state
[14,15,16,17]. Embryonic lethal mouse genes can also have
disease-associated orthologs in the human due to the presence of
hypomorphic mutations in the human population, which represent
a less severe loss of gene function than that observed in the mouse
knockouts [18,19,20]. Alternatively, embryonic lethal genes can
also undergo gain-of-function mutations, causing over-expression
or increased activity, which contribute to human disease in a
manner different from their mouse loss-of-function phenotype
[21,22,23].
Given that several genes known to cause lethality in mouse
knockouts also cause human disease due to point mutations or
genomic rearrangements, we hypothesise that essential genes form
an important group of disease genes that will have different
characteristics from non-essential disease genes. As mouse targeted
deletions provide a source of experimental analysis of null alleles,
we used data on lethal and viable mouse knockouts as a proxy for
human essential genes. The similar physiology and genome
structure between the mouse and human facilitate ortholog
comparison and functional identification between the two species.
To determine if differences exist between essential and non-
essential disease genes we examined several parameters in our
analyses, including the physiological systems affected by each
disease gene, the connectivity of each gene in protein-protein
interaction networks, and the genetic mechanisms by which genes
cause human disease.
Our results demonstrate that essential and non-essential disease
genes have a tendency to differ in the types of disease they cause,
the mode of disease inheritance, and the number of protein-
protein interactions in which they participate. We find that
essential disease genes comprise a major portion of disease genes,
and are associated with many types of human diseases affecting
diverse physiological systems. Additionally, non-essential disease
genes form a distinct class to essential disease genes for nearly
every parameter examined, and are also not similar in character-
istics to non-disease genes. We conclude that disease genes cannot
be considered a homogeneous group of genes, and that gene
essentiality is an important determinant of disease type.
Results
Classification of disease genes
We identified 1,965 human disease genes from OMIM’s morbid
map [24,25]. To assess whether essentiality was correlated with
particular disease gene properties, we grouped the disease genes
into viable and lethal categories, based on inference from mouse
knockout data [26,27]. Approximately 40% of human disease
genes (793/1965) had a knockout reported for their mouse
ortholog. We term human disease genes with essential mouse
orthologs (those with lethal knockout phenotypes) as ‘‘disease
lethal’’ (DL, n=673) genes and those with non-essential mouse
orthologs (those with viable knockout phenotypes) as ‘‘disease
viable’’ (DV, n=120) genes. It is important to note that the
essentiality classification is based upon mouse null alleles, whereas
human disease alleles are rarely null mutations. Therefore, when a
gene is referred to as ‘‘disease lethal’’ it is not an indication that the
human diseases associated with mutations in that gene are lethal,
but rather that complete removal of protein function causes
lethality in mouse. Importantly, in contrast to prior studies [5], we
considered all disease genes for which there is no mouse knockout
data available as a separate group of ‘‘unknown’’ disease genes
(DU, n=1172). These gene groups and classifications were used in
all subsequent analyses (Table 1, Dataset S1).
Notably, for those human disease genes with a known mouse
knockout phenotype, orthologs of essential mouse genes are more
highly represented (673/793, 85%) than orthologs of non-essential
mouse genes (120/793, 15%), a finding that contradicts prior
studies [5,6,7,8]; removing the ‘‘unknown’’ class (DU) has a
dramatic impact on the analysis of disease genes. It has been
reported that the published mouse knockout dataset is enriched for
developmental genes [28]. The percentage of total mouse
knockouts with a lethal phenotype is 66% (1299/1971). Yet for
disease genes with known mouse essentiality status, lethal genes
comprise 85% of the dataset (673/793; Table 1, Dataset S1, x2
p,0.05). Because the proportion of disease genes with essential
mouse orthologs does not simply reflect the relative proportions of
reported lethal and viable knockouts, we conclude that experi-
mental bias cannot solely explain the abundance of essential gene
orthologs among human disease genes (Dataset S1, x2p ,0.05).
We expect that additional essential genes will be found in the
DU dataset. For example, genes required for basal cellular
Table 1. Summary of the number of genes of each category characterized for each parameter examined.
Viable Lethal Disease Viable Disease Lethal Disease Unknown All Disease
Number of genes 672 1299 120 673 1172 1965
Number of genes with
protein-protein interactions
489 1093 90 310 924 1324
Number of genes with gene
ontology annotations
670 1288 119 670 1166 1955
Number of genes with
disease class annotations
- - 68 214 830 1112
Number of genes with
d i s e a s em o d eo f
inheritance classifications
- - 64 185 626 875
Number of genes with
disease gain/loss of
function classifications
- - 73 219 987 1279
Data was not available for all genes for each parameter. Some analyses were performed only for disease gene datasets, such as disease classification, and others also
evaluated for the viable and lethal datasets.
doi:10.1371/journal.pone.0027368.t001
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subgroup of essential human genes [29]. Therefore, we quantified
the percentage of housekeeping genes (from reference 30) in our
datasets as compared to the entire human genome (Dataset S2).
We find that 5.5% of the genes in the DU dataset (64/1172) have
been identified as housekeeping genes, while the percentage of
housekeeping genes overall in the human genome is only 2.5%
(609/24789) [30]. This difference is statistically significant (DU
genes vs not DU genes by housekeeping genes vs not housekeeping
genes, Dataset S1, x2p ,0.05). Additionally, as part of a large-
scale effort to generate targeted deletions in all mouse genes, an
initial analysis of 355 new mouse knockout lines has revealed that
approximately 30% exhibit embryonic lethality (http://www.
sanger.ac.uk/mouseportal/). Of the new knockouts generated, we
found that 22 are mouse orthologs of human DU genes. Of these,
6 exhibit lethal phenotypes (http://www.sanger.ac.uk/mouseportal/
), confirming that there are DL genes in the DU dataset, which were
misclassified as DV in prior studies [5]. Due to the under-
representation of housekeeping genes in mouse knockout experi-
ments and the evidence of new knockouts with lethal phenotypes, we
infer that there are additional essential genes in the DU dataset, the
presence of which, when properly annotated, would increase the
overall number of disease genes with essential functions.
The gene conservation between mouse and human orthologs of
disease genes has been assessed with respect to essentiality,
including a quantification of the frequency of orthologs of human
disease genes among genes with no phenotype, non-lethal
phenotypes, or lethal phenotypes in mouse knockout experiments
[9]. Park et al. found that human orthologs of the lethal gene
group had the most complete mapping to human disease genes,
although they did not differ significantly from the percentage of
non-lethal genes that were associated with disease [9]. However,
rather than determining the distribution of disease genes among
mouse knockout groups, in our work we have performed the
opposite analysis to determine the prevalence of lethal and viable
mouse knockout gene orthologs among all disease genes. We find
that 34% of disease genes have a mouse ortholog with a lethal
phenotype in knockout experiments (673/1965), while only 6% of
disease genes (120/1965) have a mouse ortholog with a viable
phenotype. Thus, a greater proportion of human disease genes are
orthologous to an essential mouse gene.
Essentiality affects disease gene classification by
physiological system
Essential genes have been considered non-disease genes by
others due to their presumed role in developmental defects and
associated lethality [7,8,9]. Since, on the contrary, we find that the
majority of disease genes with known essentiality status were lethal
genes, we next sought to examine the diseases with which lethal
genes are associated. Using MeSH classifications for disease genes,
we identified the disease types associated with each disease gene.
When grouped according to essentiality, disease genes differ in the
specific processes that they disrupt (Figure 1, for all DU data see
Figure S1). Thirty percent of disease lethal genes are associated
with diseases affecting more than one tissue, as compared to 19%
of all disease genes, which is a significant over-representation
(Fisher’s exact test p,0.05, Dataset S3), indicating that multiple
physiological systems are affected by disease mutations in essential
genes. DL genes, as opposed to DV or DU genes, are also highly
associated with multiple types of cancer (15% of DL genes
compared to 7% of total disease genes, Fisher’s exact test p,0.05),
which may be explained by the observation that targeted deletions
of cancer associated gene orthologs in mice often reveal a
requirement for those genes in embryonic development, while
the gene mutations observed in humans are hypomorphic alleles,
activating mutations, or mutations in somatic cells [31]. Despite a
known developmental role for their mouse orthologs, DL genes
were not significantly over-represented in developmental processes
(2% of DL genes) as compared to all disease genes (1% total
disease genes) in this analysis. Overall, we find that DL genes are
associated with a variety of diseases affecting nearly all
physiological processes, and are not restricted to causing
developmental defects.
Disease lethal genes tend to be highly connected in
protein-protein interaction networks, while disease
viable genes are less connected
Rarely are biological functions attributed to a single molecule;
instead, all components of a cell are intrinsically related and can be
thought of as a network of interacting modules. Genes that are
highly connected in protein-protein interaction (PPI) networks
may therefore affect multiple biological processes when mutated,
due to disruption of interactions with a variety of other genes in
the network. Based on the finding that DL genes are highly
represented in diseases affecting multiple physiological systems, we
examined the connectivity of proteins encoded by different types
of disease genes in PPI networks. Previous studies have failed to
distinguish between proteins encoded by genes of unknown
essentiality and those encoded by genes that are non-essential
[5]. This fundamental gene classification difference influences the
conclusions drawn from the resulting PPI networks. Accordingly,
we separately considered essential, non-essential and unknown
essentiality disease proteins for PPI network analysis (Figure 2).
Our results show that DL proteins have a higher average degree
(more interactions for each protein) than DV and V proteins
(Table 2). We found that L proteins have the highest maximal
degree (138) and average degree (3.9) when compared to all other
groups, indicating that L proteins have many interactions. The
variation in connectivity among different gene classes is not simply
a function of the number of proteins in each class, as the ratio of
nodes to interactions varies for each gene group (Dataset S4, x2
p,0.05).
Our analysis of the PPI for proteins with unknown essentiality
suggests that the DU group contains a mixture of essential and
non-essential proteins. The DU network (consisting of interactions
between DU proteins and those of any other group) contains the
largest number of individual components (224), yet the majority of
the proteins (89%) and interactions (96%) are within the largest
connected component. Therefore, there are many small compo-
nents with few proteins and interactions on the periphery of the
DU network, which may represent the non-essential proteins
within the DU group. We find that DU proteins participate in a
similar number of interactions to L proteins (Average Degree,
Table 2). The degree distributions (Table 2) verify the DU network
is more similar to the DL network in connectivity (Wilcoxon–
Mann–Whitney and Kolmogorov–Smirnov tests, both p,0.05),
than to the DV network. The outlying data points in the prior
analysis of viable disease gene PPI networks [5] presumably reflect
the inclusion of essential genes that have no mouse knockout (that
we classify as DU) in their viable gene dataset (Table 2).
Disease proteins segregate to different cellular
compartments based on essentiality
Interactions between proteins can only occur when those
proteins are co-localized. In yeast, it has been shown that sub-
cellular localization affects the degree of network interactions, with
nuclear proteins being more highly connected than those in the
The Role of Essential Genes in Human Disease
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interactions for DV and DL proteins, we tested whether this was a
result of differences in the sub-cellular localization of the proteins.
Using Gene Ontology (GO) annotations [GO, 33], we found that
viable and lethal genes vary in the cellular compartments to which
they are localized (Figure 3). Both DL genes and L genes, which
are highly connected, are statistically overrepresented in the
nucleus (46.45% and 50.8% respectively, see Dataset S5 for
statistical analysis data, and Text File S1 for a description of
statistical data files). In contrast, DV genes, in addition to V genes
generally, are enriched for localization to the plasma membrane
(Fisher’s exact test p,0.05). However, DV genes are also
statistically overrepresented in the extracellular region (Fisher’s
exact test p,0.05). Our findings on sub-cellular localization are in
agreement with those for yeast proteins [32], indicating that DL
genes may show a greater number of PPIs due to their higher
Figure 1. Physiological system analysis of disease genes. Distribution of all Disease genes (D), Disease Viable genes (DV) and Disease Lethal
genes (DL) in different disease classes, according to the physiological system affected. The D set corresponds to all disease genes without separation
according to essentiality.
doi:10.1371/journal.pone.0027368.g001
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viable (DV) and disease lethal (DL). For clarity, interactions are only displayed in the figure if both interacting partners have the same
classification (e.g. DV-DV interactions). However, statistical analysis (Table 2) was performed for all interactions (e.g. proteins of the same classification
interacting and proteins of different classifications interacting). The color corresponds to node degree (relative to each network) as indicated for each
panel, with the lowest degrees in red and highest degrees in purple. The node degree denotes the number of PPIs for a given gene.
doi:10.1371/journal.pone.0027368.g002
Table 2. Protein-Protein Interaction network properties of disease genes.
Largest Connected Component
Proteins Inter-actions Max Degree Avg Degree Comps Proteins Inter-actions Avg Degree
Disease Lethal 1943 2778 104 2.9 70 91% 96% 3.0
Disease Viable 1535 1600 92 2.1 151 71% 81% 2.4
Lethal 3638 7083 138 3.9 86 94% 98% 4.1
Viable 1436 1654 71 2.3 86 84% 91% 2.5
Disease Un-known 5116 8918 92 3.5 224 89% 96% 3.8
Data for PPI networks for disease lethal (DL), disease viable (DV), lethal (L), viable (V) and disease unknown (DU) genes. ‘‘Proteins’’ represent the sum of proteins in a
given group (DL, DV, L, V or DU) and their interacting partners (from any group). Statistical analysis was performed for all interactions (e.g. proteins of the same
classification and proteins of different classifications). The total number of PPIs are indicated under ‘‘Interactions’’ and the number of PPIs for the most highly connected
protein is indicated under ‘‘MaxDegree’’. ‘‘Average Degree’’ corresponds to the mean number of PPIs for all interacting proteins. ‘‘Comps’’ designates the number of
independent groups (components) of interactions, the largest of which comprises the ‘‘Largest Connected Component’’. The percentages of proteins and interactions,
and the average degree found within the largest connected component are given.
doi:10.1371/journal.pone.0027368.t002
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differences in the subcellular localization of DL and DV genes,
differences in molecular function and biological process are also
detected between groups according to GO annotations (Figure S2).
Essentiality does not affect disease mechanism
Genetic alterations that contribute to disease can manifest as a
result of loss of protein function, gain of a new or enhanced/
dysregulated protein function, or be a consequence of large
chromosome or gene rearrangements, such as translocations that
generate chimaeric proteins (classified as ‘‘other’’). We used the
characterization of disease mutations in OMIM [24] to classify
such functional changes for disease genes. Our results show that
essentiality does not appear to correlate with the propensity of a
disease to be originated by gain or loss-of-function mutations in a
gene. Independent of essentiality, the majority of diseases arise
from loss-of-function mechanisms (around 70%) and only a small
number are caused by a gain-of-function mutations (around 10%),
or chromosomal translocations (Figure 4, Dataset S5). However, it
is possible that these results are due to limited data availability or
our classification methods. Furthermore, the low proportion of
inherited diseases associated with translocations is likely due to
infertility associated with abnormal karyotypes.
Disease lethal genes are more likely to demonstrate a
dominant mode of inheritance than other disease classes
Although genes from all groups seemingly cause disease
predominantly through loss-of-function mechanisms, it is possible
that essentiality may affect the mode of inheritance of disease
genes. We therefore classified disease gene mutations as autosomal
dominant, autosomal recessive, or sex-linked, and categorized
them according to essentiality. Importantly, for this study we
included any mutant allele with a described mode of inheritance,
so a particular gene could be included in both the autosomal
dominant and autosomal recessive categories if it had different
mutations exhibiting those inheritance patterns. The frequency of
disease mutations with sex-linked inheritance is below 10% for all
of the groups (Figure 5). It was observed that the DL gene set
showed a higher proportion of autosomal dominant mutations
than autosomal recessive (Fisher’s exact test p,0.05, Dataset S5).
The high representation of dominant inheritance patterns in
essential genes may be reflective of actual semi-dominant
Figure 3. GO analysis of disease genes. Distribution of Viable (V), Lethal (L), Disease Viable (DV), Disease Lethal (DL), and all disease (D) proteins
analysed for cellular localization according to GO terms.
doi:10.1371/journal.pone.0027368.g003
Figure 4. Disease mechanism analysis. Classification of disease mechanism in the total disease gene set (D, red bars), and Disease Viable gene
(DV, green bars) and Disease Lethal gene (DL, blue bars) subsets. Other refers to diseases caused by chromosomal translocations or chimeric proteins.
doi:10.1371/journal.pone.0027368.g004
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and lethality a homozygous phenotype.
Discussion
To refine understanding of the properties of human disease
genes, we classified disease genes as essential or non-essential, and
assessed whether these two types of disease genes have specific
attributes for a variety of parameters. We also considered those
disease genes with unknown essentiality as a separate group. We
propose that this separation allows for an improved understanding
of the features of human disease genes, building upon the finding
that disease genes with essential and non-essential orthologs differ
in nearly every parameter for which they were studied. Our
findings are based on the current annotations of gene phenotypes
in the mouse knockout literature. Although in some cases mouse
knockouts of human disease genes have demonstrated phenotypes
that are not readily comparable to the human disease state [34],
the inability to assess essentiality in the human necessitates
inferring essentiality from other organisms. The mouse is clearly
the most similar model organism for which there is essentiality
data. Furthermore, large-scale mouse knockout projects will in
future provide additional data on essentiality for consideration
[35].
Separating disease genes according to their essentiality status
provides insights that expand upon observations from prior studies
on disease gene PPI networks [5,36,37]. Our results agree with
prior studies that reported a central position for DL genes in PPI
networks [5,37]. However, using our classification system for
disease genes where those of unknown essentiality are classified as
a separate group, we find that more disease genes can be classified
as essential rather than non-essential. Therefore, our interpreta-
tion of the PPI network analysis differs from prior studies. Mainly,
as DL genes constitute the majority of disease genes, and DL genes
have multiple PPIs acting as hubs in the PPI network, we conclude
that it is very likely that disease genes are found at highly
connected central positions in PPI networks.
At the molecular level, disease genes are segregated to different
cellular regions when considered in the context of essentiality. The
number of PPIs differs for the DL and DV gene groups, although
that may be due to differences in sub-cellular localization. DL
genes are both found to have more interactions and to be more
likely to be localized to the nucleus. It has been demonstrated that
nuclear proteins have higher numbers of interaction partners in
PPI networks [32], which may explain the basis for the difference
in connectivity between DL and DV genes.
Prior studies have suggested that essential genes contribute to
human disease by causing spontaneous miscarriages and birth
defects [5,7,8,9,37]. While this conclusion is reasonable for the null
alleles of DL genes, we conclude (from our analysis of the
physiological systems affected by disease genes) that DL genes also
contribute to adult disease in humans due to additional disease
alleles that do not represent functional null alleles. Therefore, the
definition of essentiality needs to be precisely applied to null alleles.
A consideration that other alleles of essential genes, such as
hypomorphic alleles, may not have lethal phenotypes needs to be
incorporated into bioinformatic studies of disease genes. Indeed
our study reveals that DL genes are more highly associated with
diseases that affect multiple physiological systems. This finding
suggests that disease lethal genes have pleiotrophic functions. For
example, many house-keeping genes are found within the lethal
group, and these genes are likely to function in many or all cell
types. Previous studies have suggested that house-keeping genes,
defined as genes with ubiquitous expression patterns, are essential
for organism survival [29] and, as a consequence, ‘mild’ mutations
in these genes will cause diseases with symptoms in several tissues.
An analysis of ubiquitously expressed genes as compared to human
disease genes revealed that the two classes of genes differed in
evolutionary and functional properties [29]. However, ubiquitous
expression is not a comprehensive indicator of essentiality, and
genes with housekeeping functions may not necessarily have lethal
knockout phenotypes. Our work, thus, demonstrates that when
essentiality, as inferred by mouse knockout phenotypes, is
considered explicitly, disease genes themselves display differing
characteristics based on their essentiality status.
Interestingly, DL genes were found to be over-represented in
cancer. Many oncogenes are associated with cell proliferation and
death mechanisms. While disruption of these processes during
embryonic development would likely prevent the survival of the
organism, cancers commonly result from somatic cell mutations
disrupting normal controls of the cell cycle [31]. Indeed, cancer
can be viewed as a developmental disease [38,39,40], because
developmental genes promoting cell proliferation become reacti-
vated in the adult and drive proliferation in an uncontrolled
fashion. A bioinformatic prediction strategy for identifying cancer
genes has been developed, although the role of essential genes has
not explicitly been incorporated into this model [41]. Our results
suggest that identifying essential genes may further refine the
prediction of genes likely to be associated with causing cancer. DV
genes primarily affect systems that are not required for basic
survival of the organism. For example, while a high percentage of
disease viable genes are associated with psychiatric and immune
system diseases, they are under-represented among cardiovascular
diseases.
We also detected a difference in the mode of inheritance of
disease genes when classified according to essentiality. We find that
disease lethal genes are more likely to demonstrate an autosomal
dominant mode of inheritance. This reflects the tendency for
disease to occur in the heterozygous state in these individuals, and
that homozygosity for disease mutations would present a more
severe phenotype causing lethality. Human disease mutations are
not often nulls, and essentiality and disease can be considered on a
spectrum with respect to mutant alleles. While severe mutant
Figure 5. Mode of inheritance of disease genes. Proportion of
disease genes inherited in an autosomal dominant pattern (AD),
autosomal recessive pattern (AR) or X-lined pattern (X) in the total
Disease gene set (D, red bars), or Disease Viable gene (DV, green bars)
and Disease Lethal gene subsets (DL, blue bars).
doi:10.1371/journal.pone.0027368.g005
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confer lethality, hypomorphic alleles simply reduce protein
function below an optimal level, resulting in a phenotype
recognized as disease. In this manner, lethal genes can have
mutations that only reduce protein function and therefore present
as disease in the human population, allowing for inheritance of
these more mild alleles in genetic diseases.
From our study we can now present a composite profile of
human disease gene types. We have found that DL and DV genes
differ from each other in many of the characteristics we have
analyzed. Overall, DL genes are more likely to be involved in
more protein-protein interactions, encode nuclear proteins, be
associated with diseases such as cancer and those affecting multiple
systems, and have an autosomal dominant mode of inheritance. In
contrast, DV genes have a tendency to localize to the plasma
membrane or extracellular regions, be involved in neurological or
immune system diseases, and have an autosomal recessive mode of
inheritance.
We have shown that disease genes are not a homogenous group
and should be considered in the context of the functional
importance of the gene with which they are associated. Moreover,
in contrast to prior studies [5,6], we find that when disease genes
with unknown essentiality are considered as a separate group from
non-essential disease genes, the majority of disease genes are
essential. We propose that rather than solely contributing to
spontaneous miscarriages or birth defects due to severe loss of
function mutations, as has been stated in prior studies [7,8,9], DL
genes have a variety of disease associated alleles that represent a
spectrum of human diseases affecting both development and adult
physiological systems. The recognition that disease genes are not a
homogenous subset of human genes, and that essential genes
cannot be excluded from consideration as candidates for all types
of human disease genes, will aid in the identification of candidate
disease gene loci for a variety of human diseases.
Materials and Methods
Data retrieval
We obtained the human–mouse orthology and mouse viable/
lethal phenotype data from Mouse Genome Informatics (http://
www.informatics.jax.org) [26], to give 2,360 human genes with
information about lethality status of the mouse knockout of their
ortholog in the whole genome, without consideration of whether
the gene is annotated as a human disease gene. These were
verified manually by checking phenotypes using PubMed. We
considered the annotations of embryonic, postnatal, prenatal and
perinatal lethality as lethal phenotypes. These data are an
appropriate proxy for gene essentiality in humans and are herein
mentioned as viable and lethal. After removing redundancy, we
find 1,299 and 672 human orthologs of mouse lethal and viable
genes respectively. Only mouse genes with known phenotypes
resulting from targeted deletions (knockouts) were included in the
study.
To create the human protein-protein interaction network,
encoded proteins for each gene were determined from the Entrez
gene database and interactions were derived from multiple
sources: BioGRID (http://www.thebiogrid.org) [42], BIND
(http://www.bind.ca) [43] and HPRD (http://www.hprd.org)
[44] and filtered from the NCBI ‘‘interactions’’ file (ftp://ftp.
ncbi.nlm.nih.gov/gene/GeneRIF). Interaction data contained in
these datasets are derived from multiple sources, such as Y2H, co-
imunoprecipitation and so on. The resulting protein-protein
interaction network consisted of 8,880 nodes (proteins) with
33,979 edges (interactions).
A dataset of 1,965 disease genes was retrieved from the OMIM
database [24], and cross-referenced with OMIM’s morbid map to
provide disease-gene-phenotype relationships [25]. Of these, 1,324
of the disease genes were present in the protein-protein network;
90 of which could be found in the viable network and 310 in the
lethal network.
From Eisenberg and Levanon [30], we obtained 600 house-
keeping genes and converted the given nucleotide accessions to
gene loci names and Entrez accession numbers using the NCBI
Entrez gene database.
Disease classification
The classification of the different disease genes into their
corresponding disease categories was based on the Medical
Subject Headings controlled vocabulary (MeSH; http://www.
nlm.nih.gov/mesh/meshhome.html) [45] as previously described
[46]. MeSH hierarchically describes diseases (in addition to other
life science categories), e.g., diseases to digestive system diseases to
digestive system neoplasms and so on. High level terms were
combined with classifications from Goh [5] to provide a consistent
annotation of disease as in [46].
Network connectivity and centrality measurements
Cytoscape (version 2.62) [47] and Navigator (version 2.1.13)
[48] were used to visualize the protein-protein network and to
analyse the number of highly connected proteins (hubs) and the
number of hub-hub connections in the network belonging to each
dataset. R [49], using the igraph package [50], was used to verify
network properties for each subset of nodes. Degree is defined as
the the total number of edges (interactions) incident upon a node
(protein), the distribution of which gives a probability distribution
of degrees over the whole network. Components are the number of
maximally connected independent groups of interactions, the
largest of which is the largest connected component. Self-edges
were ignored throughout. Quantitative analyses include all
interactions where one (or both) of the partners is a member of
the category (DL, DV, L, V or DU, Table 2). For Figure 2, to
improve image clarity, only interactions observed between like-
category partners (e.g. DV-DV) are visualized in a force-directed
layout.
Protein cellular localization, function and processes
Gene Ontology (GO) annotations for human genes were
retrieved using the BINGO 2.3 plugin [51] present in Cytoscape
[47] and from GO directly (http://www.geneonotology.org/GO.
downloads.ontology.shtml) [33]. GO slim corresponds to a higher-
level version of GO ontologies, that contains a subset of terms
representative of the complete GO and were also downloaded
from GO (http://www.geneontology.org/GO.slims.shtml). Func-
tional analysis corresponds to gene ontology terms from the
molecular function category that have the term "activity" in their
name.
Disease Mechanism
We exploited the rich annotation of OMIM to classify diseases
as resulting from gain-of-function or loss-of-function mechanisms.
Mutations that cause the formation of chimeric proteins due to
translocations are included in a further ‘other’ category. For each
OMIM record an automated simplistic word scoring process was
used, whereby discriminating words and word stems, e.g.
‘‘deficiency’’, ‘‘neomorphic’’, ‘‘activation’’, correspond to each
category (gain, loss, neutral). The type of mutation was thus
chosen according to the category that presented the highest word
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was used to exclude method bias and error using Bishop for Ruby
(http://bishop.rubyforge.org/), based on the Reverend classifier
for Python (http://divmod.org/trac/wiki/DivmodReverend).
OMIM records known to represent gain, loss or neutral
consequences were manually selected and used as training sets.
Frequent words were excluded from training and classification, as
were non discriminating words common to each grouping. For
example, words shared by a gain record and a loss record in the
training set were excluded from our classification.
A separation of monogenic diseases from polygenic diseases was
also performed (Table 3). The results with and without the
polygenic diseases were similar. The group without the polygenic
diseases is presented.
Mode of inheritance
The separation of the disease essential, disease non-essential,
and disease unknown genes into the different modes of inheritance
(autosomal dominant, autosomal recessive and sex-linked) was
based on the categorization provided by Blekhman [52].
Statistical analyses
Statistical analyses were performed throughout in R [49]. P-
values were calculated using Fisher’s exact, Wilcoxon–Mann–
Whitney or Kolmogorov–Smirnov tests as indicated. The
Benjamin & Hochberg False Discovery Rate (FDR) was used to
calculate corrected p-values [53].
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